nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP9—adipose tissue—atherosclerosis	0.0204	0.235	CbGeAlD
Vildagliptin—DPP4—blood vessel—atherosclerosis	0.0198	0.228	CbGeAlD
Vildagliptin—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.0195	0.0213	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Lovastatin—atherosclerosis	0.0149	0.0163	CcSEcCtD
Vildagliptin—Skin exfoliation—Niacin—atherosclerosis	0.0147	0.0161	CcSEcCtD
Vildagliptin—DPP9—liver—atherosclerosis	0.0143	0.165	CbGeAlD
Vildagliptin—Hepatic function abnormal—Simvastatin—atherosclerosis	0.0139	0.0153	CcSEcCtD
Vildagliptin—Pancreatitis—Rosuvastatin—atherosclerosis	0.013	0.0143	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Niacin—atherosclerosis	0.0128	0.014	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Pravastatin—atherosclerosis	0.0126	0.0138	CcSEcCtD
Vildagliptin—Liver function test abnormal—Ezetimibe—atherosclerosis	0.0118	0.0129	CcSEcCtD
Vildagliptin—Dermatitis bullous—Niacin—atherosclerosis	0.0117	0.0128	CcSEcCtD
Vildagliptin—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0114	0.0125	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.0112	0.0123	CcSEcCtD
Vildagliptin—Pancreatitis—Lovastatin—atherosclerosis	0.011	0.0121	CcSEcCtD
Vildagliptin—Pancreatitis—Ezetimibe—atherosclerosis	0.0108	0.0119	CcSEcCtD
Vildagliptin—Hepatitis—Rosuvastatin—atherosclerosis	0.0106	0.0117	CcSEcCtD
Vildagliptin—Liver function test abnormal—Niacin—atherosclerosis	0.0103	0.0113	CcSEcCtD
Vildagliptin—Pancreatitis—Simvastatin—atherosclerosis	0.0103	0.0113	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.0103	0.0112	CcSEcCtD
Vildagliptin—Liver function test abnormal—Pravastatin—atherosclerosis	0.0102	0.0111	CcSEcCtD
Vildagliptin—DPP4—connective tissue—atherosclerosis	0.0102	0.117	CbGeAlD
Vildagliptin—Nasopharyngitis—Pravastatin—atherosclerosis	0.00986	0.0108	CcSEcCtD
Vildagliptin—Infestation NOS—Ezetimibe—atherosclerosis	0.00985	0.0108	CcSEcCtD
Vildagliptin—Infestation—Ezetimibe—atherosclerosis	0.00985	0.0108	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00979	0.0107	CcSEcCtD
Vildagliptin—Pancreatitis—Pravastatin—atherosclerosis	0.00934	0.0102	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00932	0.0102	CcSEcCtD
Vildagliptin—Flatulence—Rosuvastatin—atherosclerosis	0.00913	0.00999	CcSEcCtD
Vildagliptin—Hepatitis—Lovastatin—atherosclerosis	0.00902	0.00987	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00885	0.00969	CcSEcCtD
Vildagliptin—DPP4—cardiovascular system—atherosclerosis	0.00885	0.102	CbGeAlD
Vildagliptin—Hepatitis—Ezetimibe—atherosclerosis	0.00884	0.00968	CcSEcCtD
Vildagliptin—Oedema peripheral—Ezetimibe—atherosclerosis	0.00871	0.00954	CcSEcCtD
Vildagliptin—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00869	0.00952	CcSEcCtD
Vildagliptin—Weight increased—Pravastatin—atherosclerosis	0.00867	0.00949	CcSEcCtD
Vildagliptin—Angioedema—Rosuvastatin—atherosclerosis	0.00846	0.00927	CcSEcCtD
Vildagliptin—Hepatitis—Simvastatin—atherosclerosis	0.00843	0.00923	CcSEcCtD
Vildagliptin—Chills—Lovastatin—atherosclerosis	0.00809	0.00886	CcSEcCtD
Vildagliptin—Angiopathy—Ezetimibe—atherosclerosis	0.00802	0.00879	CcSEcCtD
Vildagliptin—Arthralgia—Rosuvastatin—atherosclerosis	0.00788	0.00863	CcSEcCtD
Vildagliptin—DPP4—adipose tissue—atherosclerosis	0.0078	0.0899	CbGeAlD
Vildagliptin—Hepatitis—Niacin—atherosclerosis	0.00774	0.00848	CcSEcCtD
Vildagliptin—Flatulence—Lovastatin—atherosclerosis	0.00773	0.00847	CcSEcCtD
Vildagliptin—Malnutrition—Ezetimibe—atherosclerosis	0.0077	0.00843	CcSEcCtD
Vildagliptin—Oedema peripheral—Niacin—atherosclerosis	0.00763	0.00835	CcSEcCtD
Vildagliptin—Hepatitis—Pravastatin—atherosclerosis	0.00762	0.00835	CcSEcCtD
Vildagliptin—Flatulence—Ezetimibe—atherosclerosis	0.00759	0.00831	CcSEcCtD
Vildagliptin—Chills—Simvastatin—atherosclerosis	0.00757	0.00829	CcSEcCtD
Vildagliptin—Infection—Rosuvastatin—atherosclerosis	0.00751	0.00822	CcSEcCtD
Vildagliptin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00741	0.00812	CcSEcCtD
Vildagliptin—Tremor—Lovastatin—atherosclerosis	0.00735	0.00805	CcSEcCtD
Vildagliptin—Flatulence—Simvastatin—atherosclerosis	0.00723	0.00792	CcSEcCtD
Vildagliptin—Angioedema—Lovastatin—atherosclerosis	0.00717	0.00785	CcSEcCtD
Vildagliptin—Angioedema—Ezetimibe—atherosclerosis	0.00703	0.0077	CcSEcCtD
Vildagliptin—Angiopathy—Niacin—atherosclerosis	0.00703	0.00769	CcSEcCtD
Vildagliptin—Chills—Niacin—atherosclerosis	0.00695	0.00761	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00689	0.00754	CcSEcCtD
Vildagliptin—Tremor—Simvastatin—atherosclerosis	0.00688	0.00753	CcSEcCtD
Vildagliptin—Chills—Pravastatin—atherosclerosis	0.00684	0.00749	CcSEcCtD
Vildagliptin—Malnutrition—Niacin—atherosclerosis	0.00674	0.00738	CcSEcCtD
Vildagliptin—Angioedema—Simvastatin—atherosclerosis	0.00671	0.00735	CcSEcCtD
Vildagliptin—Arthralgia—Lovastatin—atherosclerosis	0.00668	0.00732	CcSEcCtD
Vildagliptin—Flatulence—Niacin—atherosclerosis	0.00664	0.00727	CcSEcCtD
Vildagliptin—Arthralgia—Ezetimibe—atherosclerosis	0.00655	0.00718	CcSEcCtD
Vildagliptin—Flatulence—Pravastatin—atherosclerosis	0.00654	0.00716	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00651	0.00713	CcSEcCtD
Vildagliptin—Constipation—Rosuvastatin—atherosclerosis	0.00646	0.00708	CcSEcCtD
Vildagliptin—Infection—Lovastatin—atherosclerosis	0.00636	0.00697	CcSEcCtD
Vildagliptin—Arthralgia—Simvastatin—atherosclerosis	0.00625	0.00684	CcSEcCtD
Vildagliptin—Infection—Ezetimibe—atherosclerosis	0.00624	0.00684	CcSEcCtD
Vildagliptin—Tremor—Pravastatin—atherosclerosis	0.00622	0.00681	CcSEcCtD
Vildagliptin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00616	0.00675	CcSEcCtD
Vildagliptin—Angioedema—Niacin—atherosclerosis	0.00616	0.00674	CcSEcCtD
Vildagliptin—Skin disorder—Ezetimibe—atherosclerosis	0.0061	0.00668	CcSEcCtD
Vildagliptin—Angioedema—Pravastatin—atherosclerosis	0.00606	0.00664	CcSEcCtD
Vildagliptin—Urticaria—Rosuvastatin—atherosclerosis	0.006	0.00658	CcSEcCtD
Vildagliptin—Oedema—Simvastatin—atherosclerosis	0.00599	0.00656	CcSEcCtD
Vildagliptin—Infection—Simvastatin—atherosclerosis	0.00595	0.00652	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00584	0.00639	CcSEcCtD
Vildagliptin—Arthralgia—Niacin—atherosclerosis	0.00574	0.00628	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00572	0.00627	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.0057	0.00624	CcSEcCtD
Vildagliptin—Arthralgia—Pravastatin—atherosclerosis	0.00565	0.00619	CcSEcCtD
Vildagliptin—Fatigue—Lovastatin—atherosclerosis	0.00552	0.00605	CcSEcCtD
Vildagliptin—Oedema—Niacin—atherosclerosis	0.0055	0.00602	CcSEcCtD
Vildagliptin—Constipation—Lovastatin—atherosclerosis	0.00548	0.006	CcSEcCtD
Vildagliptin—DPP4—liver—atherosclerosis	0.00547	0.063	CbGeAlD
Vildagliptin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00546	0.00598	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00542	0.00594	CcSEcCtD
Vildagliptin—Asthenia—Rosuvastatin—atherosclerosis	0.00542	0.00594	CcSEcCtD
Vildagliptin—Oedema—Pravastatin—atherosclerosis	0.00542	0.00593	CcSEcCtD
Vildagliptin—Fatigue—Ezetimibe—atherosclerosis	0.00542	0.00593	CcSEcCtD
Vildagliptin—Infection—Pravastatin—atherosclerosis	0.00538	0.00589	CcSEcCtD
Vildagliptin—Constipation—Ezetimibe—atherosclerosis	0.00537	0.00588	CcSEcCtD
Vildagliptin—Skin disorder—Niacin—atherosclerosis	0.00534	0.00585	CcSEcCtD
Vildagliptin—Hyperhidrosis—Niacin—atherosclerosis	0.00532	0.00582	CcSEcCtD
Vildagliptin—Hyperhidrosis—Pravastatin—atherosclerosis	0.00524	0.00573	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00517	0.00566	CcSEcCtD
Vildagliptin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00517	0.00566	CcSEcCtD
Vildagliptin—Fatigue—Simvastatin—atherosclerosis	0.00517	0.00566	CcSEcCtD
Vildagliptin—Constipation—Simvastatin—atherosclerosis	0.00512	0.00561	CcSEcCtD
Vildagliptin—Urticaria—Lovastatin—atherosclerosis	0.00509	0.00557	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00501	0.00549	CcSEcCtD
Vildagliptin—Dizziness—Rosuvastatin—atherosclerosis	0.005	0.00547	CcSEcCtD
Vildagliptin—Urticaria—Ezetimibe—atherosclerosis	0.00499	0.00547	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00494	0.0054	CcSEcCtD
Vildagliptin—Urticaria—Simvastatin—atherosclerosis	0.00476	0.00521	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00475	0.0052	CcSEcCtD
Vildagliptin—Headache—Rosuvastatin—atherosclerosis	0.00474	0.00519	CcSEcCtD
Vildagliptin—Fatigue—Pravastatin—atherosclerosis	0.00467	0.00511	CcSEcCtD
Vildagliptin—Constipation—Pravastatin—atherosclerosis	0.00463	0.00507	CcSEcCtD
Vildagliptin—Asthenia—Lovastatin—atherosclerosis	0.0046	0.00503	CcSEcCtD
Vildagliptin—Asthenia—Ezetimibe—atherosclerosis	0.00451	0.00494	CcSEcCtD
Vildagliptin—Nausea—Rosuvastatin—atherosclerosis	0.00449	0.00492	CcSEcCtD
Vildagliptin—Diarrhoea—Lovastatin—atherosclerosis	0.00438	0.0048	CcSEcCtD
Vildagliptin—Urticaria—Niacin—atherosclerosis	0.00437	0.00479	CcSEcCtD
Vildagliptin—Urticaria—Pravastatin—atherosclerosis	0.0043	0.00471	CcSEcCtD
Vildagliptin—Asthenia—Simvastatin—atherosclerosis	0.0043	0.00471	CcSEcCtD
Vildagliptin—Diarrhoea—Ezetimibe—atherosclerosis	0.0043	0.00471	CcSEcCtD
Vildagliptin—Dizziness—Lovastatin—atherosclerosis	0.00424	0.00464	CcSEcCtD
Vildagliptin—Dizziness—Ezetimibe—atherosclerosis	0.00415	0.00455	CcSEcCtD
Vildagliptin—Diarrhoea—Simvastatin—atherosclerosis	0.0041	0.00449	CcSEcCtD
Vildagliptin—Headache—Lovastatin—atherosclerosis	0.00401	0.00439	CcSEcCtD
Vildagliptin—Dizziness—Simvastatin—atherosclerosis	0.00396	0.00434	CcSEcCtD
Vildagliptin—Asthenia—Niacin—atherosclerosis	0.00395	0.00432	CcSEcCtD
Vildagliptin—Headache—Ezetimibe—atherosclerosis	0.00394	0.00431	CcSEcCtD
Vildagliptin—Asthenia—Pravastatin—atherosclerosis	0.00389	0.00426	CcSEcCtD
Vildagliptin—Nausea—Lovastatin—atherosclerosis	0.0038	0.00417	CcSEcCtD
Vildagliptin—Diarrhoea—Niacin—atherosclerosis	0.00376	0.00412	CcSEcCtD
Vildagliptin—Headache—Simvastatin—atherosclerosis	0.00375	0.00411	CcSEcCtD
Vildagliptin—Nausea—Ezetimibe—atherosclerosis	0.00373	0.00409	CcSEcCtD
Vildagliptin—Diarrhoea—Pravastatin—atherosclerosis	0.00371	0.00406	CcSEcCtD
Vildagliptin—Dizziness—Niacin—atherosclerosis	0.00364	0.00398	CcSEcCtD
Vildagliptin—Dizziness—Pravastatin—atherosclerosis	0.00358	0.00392	CcSEcCtD
Vildagliptin—Nausea—Simvastatin—atherosclerosis	0.00356	0.0039	CcSEcCtD
Vildagliptin—Headache—Niacin—atherosclerosis	0.00345	0.00377	CcSEcCtD
Vildagliptin—Headache—Pravastatin—atherosclerosis	0.00339	0.00372	CcSEcCtD
Vildagliptin—Nausea—Niacin—atherosclerosis	0.00327	0.00358	CcSEcCtD
Vildagliptin—Nausea—Pravastatin—atherosclerosis	0.00322	0.00352	CcSEcCtD
